Development
One with the world? A new look at brains transformed by psychedelics.
October 10, 2026 Development Source: Ars Technica
Share this article
Half of the participants ranked their session among the most meaningful experiences of their lives, and 24 put it in their personal top five. Stolkier and his colleagues started analyzing their brain scan data to find out why.
Measuring global functional connectivity—how much influence each patch of cortex exerts over the rest—the team found that, when participants had their eyes closed, sensory regions lost sway while associative regions gained. “It seems like the brain’s ability to construct reality, or imagination, or our associations, our beliefs, our sense of self—these faculties had more dominance over sensory areas,” Stoliker says, stressing that the interpretation is a hypothetical. “This could help explain why people have meaningful, complex imagery experiences, why they have mystical experiences with imagery that is personally relevant to them.”
Another observation the team made was that connections within each brain network weakened, connections between networks strengthened. The brain’s modularity, a parameter that describes how cleanly neurons stay sorted into specialist teams, dropped across all four parts of the experimental sequence.
What’s more, researchers found that, when sober, activity in a brain with its eyes shut looked very different from a brain watching a movie. Under psilocybin, that difference nearly evaporated. In the visual network, the gap between eyes-open and eyes-closed connectivity shrank by 85 percent. The results from the EEG session independently confirmed that, with alpha-band activity (normally a marker of the brain gating visual input) reduced by nearly half.
“When somebody takes a psychedelic and they’re able to close their eyes and see complex imagery, there seems to be less boundary between the internal and external world than we ordinarily experience,” Stoliker says.
Regardless of these details, the results rather accurately reproduced the chaos in the brain so many researchers claimed psychedelics caused. This chaos, though, turned into order when the team processed their data in a slightly unorthodox way.
The problem with this analysis is that it runs the risk of missing ordered structures that appear for a brief period and then disappear into chaos.
The second analysis is averaging over people. Having produced one such number per participant, the standard approach then pools all of them into a group average, on the assumption that individual differences are noise that will be canceled out. Stoliker’s study was focused on individual experiences, so he wanted to avoid that.
Instead, the team fed the moment-by-moment activity of 332 brain regions into CEBRA, a machine-learning tool that compressed the data down to its essential structure while preserving the order of events. For each individual, it produced a trajectory—a path traced through a three-dimensional space, one point for each moment of the scan.
“When they’re not under psilocybin, the brain activity is less differentiated by context,” Stoliker says. “But under psilocybin, we see that the activity becomes organized across time and more clearly differentiated by context.” The trajectories separated into four distinct clusters corresponding to rest, meditation, music, and the movie. A classifier could read a moment of brain activity and say which one the person was in.
It turned out the performance of that classifier scaled with how profound the participants described their experience as being.
To find out which parts of the brain were doing the work, the team replaced one network’s psilocybin activity with its sober version and checked how badly the classifier degraded. The default mode network and the visual network each accounted for over 20 percent of the effect. “The default mode network is strongly associated with the sense of self: daydreaming, mind wandering, thinking about yourself. It’s often been called the narrative self,” Stoliker explains. “On the other end of this gradient, more externally oriented, is the visual system.”
Under psilocybin, the two became less differentiated, which the team thinks explains why participants reported a subjective experience of the self and the external world becoming less separate, a state Stoliker calls “embeddedness.”
“Theoretically, we could suggest that psychedelics are temporarily altering the organization of brain networks that ordinarily help maintain this separation that we experience,” he says. “It really challenges the idea of whether the internal world and external world are separate and highlights the idea that the brain may be responsible for constructing both.”
The day after the session, participants rated whether various things had shifted, like sense of connection to themselves, to others, to nature, along with peace, acceptance, and creativity, all on a scale running from –100 to 100. “For the vast majority of our participants, we found they had positive psychological changes the next day,” Stoliker says. The data from the brain reading classifier the team used for discriminating among meditation, rest, the movie, and the music tracked with the size of that shift.
In the future, Stolkier hopes to use this for therapeutic purposes. If context isn’t just mood-setting but is mechanically shaping brain organization, Stolkier argues, then the room, the playlist, and the instructions start to look like clinical variables a clinician could deliberately tune to improve therapeutic outcomes. But there are details the team must work out first.
As of now, the researchers admit that when two people report identical “embeddedness” scores, they can potentially have very different subjective experiences. Also, all the volunteers in Stoliker’s study were healthy individuals, not patients suffering from psychological or psychiatric disorders that potential therapies using psychedelics could be aimed at.
Finally, we still don’t know how exactly variables like music or visuals should be tuned. “That’s a future avenue where we need more research to determine exactly what conditions should be optimized, and for who. It’s quite possible we would want to take different approaches for each individual, or depending on what their diagnosis is,” Stoliker says. “Still, finding this level of organization hidden underneath that disorder and chaos has some really good explanatory value.”
Nature, 2026. DOI: 10.1038/s41586-026-10910-z